Literature DB >> 22981557

Cardiac outcomes with submaximal normal stress echocardiography: a meta-analysis.

Harikrishna Makani1, Sripal Bangalore, Dan Halpern, Hetal G Makwana, Farooq A Chaudhry.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the risk of cardiac events in patients with normal stress echocardiography (SE) who attained maximal age-predicted heart rate (APHR) compared with those who did not in the setting of both normal and abnormal SE.
BACKGROUND: SE is an important tool in the risk stratification and prognosis of patients with known or suspected coronary artery disease (CAD). The prognostic value of a normal but submaximal SE (<85% of maximal APHR) is conflicting.
METHODS: PubMed, EMBASE, and CENTRAL were searched from 1980 to September 2011 for SE studies reporting cardiac outcomes in patients with known or suspected CAD stratified by achieved APHR. Both hard events (cardiac death and myocardial infarction) and total cardiac events (revascularization procedures in addition to hard events) were analyzed separately. Data on all-cause mortality were obtained when available.
RESULTS: Fourteen studies with 11,542 patients followed up for a mean duration of 32 months fulfilled the inclusion criteria. In 8 studies with 4,577 patients, the risk of hard events with normal SE (both exercise and dobutamine) was 70% higher in patients who achieved submaximal compared with those with maximal APHR (annualized event rate 2.08% vs. 0.77%; p=0.0008; 95% confidence interval [CI]: 1.25 to 2.31). In 7 studies with 5,798 patients, the risk of total cardiac events with normal SE (both exercise and dobutamine) was 127% higher in patients who achieved submaximal compared with those with maximal APHR (annualized event rate 1.87% vs. 1.02%; p<0.0001; 95% CI: 1.54 to 3.34). The risk of total cardiac events was 278% higher in patients with abnormal SE with submaximal APHR compared with those with normal SE with submaximal APHR (p<0.0001; 95% CI: 2.81 to 5.08). There was a trend toward increased all-cause mortality in patients with normal SE with submaximal compared with maximal APHR (relative risk: 1.36; p=0.15; 95% CI: 0.89 to 2.09).
CONCLUSIONS: Patients with submaximal APHR in the setting of normal SE have a higher risk of cardiovascular events than those who attained maximal stress test. Thus, the results of submaximal APHR in the setting of normal SE should be taken into consideration for more accurate risk stratification and prognosis.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981557     DOI: 10.1016/j.jacc.2012.05.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Evaluating left ventricular systolic dysfunction: Stress echocardiography.

Authors:  Edgar Argulian; Farooq A Chaudhry
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

2.  Prognostic Value of Modified Haller Index in Patients with Suspected Coronary Artery Disease Referred for Exercise Stress Echocardiography.

Authors:  Andrea Sonaglioni; Elisabetta Rigamonti; Gian Luigi Nicolosi; Michele Lombardo
Journal:  J Cardiovasc Echogr       Date:  2021-07-28

3.  Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis.

Authors:  Michael J Lipinski; Courtney M McVey; Jeffrey S Berger; Christopher M Kramer; Michael Salerno
Journal:  J Am Coll Cardiol       Date:  2013-05-30       Impact factor: 24.094

4.  Coronary flow velocity reserve during dobutamine stress echocardiography.

Authors:  José Sebastião de Abreu; José Wellington Oliveira Lima; Tereza Cristina Pinheiro Diógenes; Jordana Magalhães Siqueira; Nayara Lima Pimentel; Pedro Sabino Gomes Neto; Marília Esther Benevides de Abreu; José Nogueira Paes Júnior
Journal:  Arq Bras Cardiol       Date:  2013-12-21       Impact factor: 2.000

5.  Prognostic Value of Coronary Flow Reserve Obtained on Dobutamine Stress Echocardiography and its Correlation with Target Heart Rate.

Authors:  José Sebastião de Abreu; Eduardo Arrais Rocha; Isadora Sucupira Machado; Isabelle O Parahyba; Thais Brito Rocha; Fernando José Villar Nogueira Paes; Tereza Cristina Pinheiro Diogenes; Marília Esther Benevides de Abreu; Ana Gardenia Liberato Ponte Farias; Marcia Maria Carneiro; José Nogueira Paes
Journal:  Arq Bras Cardiol       Date:  2017-04-20       Impact factor: 2.000

6.  Comparison of 5-Year Outcomes for Patients With Coronary Artery Disease in Groups With and Without Revascularization With Different Results of Stress Echocardiography.

Authors:  Angela Zagatina; Ludmila Krylova; Yuliya Vareldzhan; Tatyana V Tyurina; Olga Clitsenko; Nadezhda Zhuravskaya
Journal:  Cardiol Res       Date:  2013-10-15

7.  Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography.

Authors:  Richard P Steeds; Richard Wheeler; Sanjeev Bhattacharyya; Joseph Reiken; Petros Nihoyannopoulos; Roxy Senior; Mark J Monaghan; Vishal Sharma
Journal:  Echo Res Pract       Date:  2019-06-01

8.  Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction Patients.

Authors:  Dana Villines; Wm Thomas Summerfelt; James R Spalding; Therese M Kitt; Rita M Kristy; Christy R Houle
Journal:  Pharmacoecon Open       Date:  2019-12

9.  Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing.

Authors:  Théo Pezel; Thierry Unterseeh; Philippe Garot; Thomas Hovasse; Marine Kinnel; Stéphane Champagne; Solenn Toupin; Francesca Sanguineti; Jérôme Garot
Journal:  J Cardiovasc Magn Reson       Date:  2021-07-05       Impact factor: 5.364

Review 10.  Myocardial Ischemia Assessment in Chronic Kidney Disease: Challenges and Pitfalls.

Authors:  Susie F C Parnham; Jonathan M Gleadle; Carmine G De Pasquale; Joseph B Selvanayagam
Journal:  Front Cardiovasc Med       Date:  2014-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.